skip to content
Primary navigation

Inhaled Corticosteroids

Drug - Inhaled Corticosteroids

June 2019

Therapeutic area - Respiratory/Asthma


Asmanex (twisthaler)
Budesonide respules
Flovent Diskus
Flovent HFA
Pulmicort Flexhaler

Armonair Respiclick
Arnuity Ellipta
Asmanex HFA
Pulmicort Respules
QVAR Redihaler

Approval criteria for nonpreferred products

  • Patient has a diagnosis of asthma AND
  • Patient had an adequate adherent trial and failure of (or contraindication to) 3 of the preferred products. Trials must be at least two weeks in duration of continuous daily use.

Note: Failure is defined as no improvement or worsening in asthma symptoms after at least two weeks of continued daily use of the inhaled corticosteroid.

Expected side effects of any agent within the class are not considered failure. Expected side effects include: 

  • bad taste
  • dysphonia
  • oropharyngeal candidiasis
  • cough
  • sore throat

See Grandfathering Criteria for patient-specific exceptions.

Quantity limit

One inhaler per month


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top